Hubbry Logo
Harry BenjaminHarry BenjaminMain
Open search
Harry Benjamin
Community hub
Harry Benjamin
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Harry Benjamin
Harry Benjamin
Harry Benjamin
View on Wikipedia
from Wikipedia

Key Information

Harry Benjamin (January 12, 1885 – August 24, 1986) was a German-American endocrinologist and sexologist, widely known for his clinical work with transgender people.[2]

Early life and career

[edit]

Benjamin was born in Berlin, and raised in a German Lutheran home.[3] His mother was German and his father at least part-Jewish in ancestry. He joined a regiment of the Prussian Guard.[4] He received his doctorate in medicine in 1912 in Tübingen for a dissertation on tuberculosis.[5] Sexual medicine interested him, but was not part of his medical studies. In a 1985 interview he recalled:

I do remember going, as a young person, to a lecture by Auguste Forel, whose book The Sexual Question was a sensation at the time and which impressed me greatly. I also met Magnus Hirschfeld very early on through a girl friend, who knew the police official Kopp, who was in charge investigating of sexual offenses. He, in turn, was a friend of Hirschfeld's, and so I met both men. That was around 1907. They repeatedly took me along on their rounds through the homosexual bars in Berlin. I especially remember the 'Eldorado' with its drag shows, where also many of the customers appeared in the clothing of the other sex. The word "transvestite" had not yet been invented. Hirschfeld coined it only in 1910 in his well-known study.[6]

Benjamin visited the United States in 1913, to work with a quack doctor who claimed to have found a cure for tuberculosis.[7] The liner in which Benjamin was returning to Germany was caught mid-Atlantic both by the outbreak of the First World War in 1914, and the Royal Navy. Given the choice of a British internment camp, as an "enemy alien", or returning to New York, he used his last dollars to travel back to America, where he made his home for the rest of his life.[8] However, he maintained and built many international professional connections and visited Europe frequently when wars allowed.

After several failed attempts to start a medical career in New York, in 1915 Benjamin rented a consulting room, in which he also slept, and started his own general medical practice.[9][10] In 1937 he moved his practice to a ground floor office suite at 728 Park Avenue in Manhattan, then briefly to 125 East 72nd Street in 1957, and sometime between 1959 and 1962 he moved his practice again to 44 East 67th Street before finally relocating to 1045 Park Avenue in 1963 where he continued to practice until his retirement in 1968.[11] Sometime before 1948, he also began maintaining an office in San Francisco where he practiced during the summer of every year (at 450 Sutter Street, Suite 2232),[12] with many of his patients coming from the nearby Tenderloin neighborhood[13]).

Work with transgender people

[edit]

Prior to arriving in the United States, Benjamin studied at the Institut für Sexualwissenschaft; from about this time onward he began to encounter and treat patients who he would later describe as transsexuals.[14][15] In the 1930s he studied in Austria with Eugen Steinach.[14] In 1948, in San Francisco,[16] Benjamin was asked by Alfred Kinsey, a fellow sexologist, to see a young patient who was anatomically male but insisted on being female.[17] Kinsey had encountered the child as a result of his interviews for Sexual Behavior in the Human Male, which was published that year.[16] This case rapidly caused Benjamin's interest in what he would come to call transsexualism,[17] realizing that there was a different condition to that of transvestism, under which adults who had such needs had been classified to that time.[citation needed][clarification needed]

Despite the psychiatrists Benjamin involved in the case not agreeing on a path of treatment, Benjamin eventually decided to treat the child with estrogen (Premarin, introduced in 1941), which had a "calming effect", and helped arrange for the mother and child to go to Germany, where surgery[specify] to assist the child could be performed but, from there, they ceased to maintain contact, to Benjamin's regret.[citation needed] However, Benjamin continued to refine his understanding and went on to treat several hundred patients with similar needs in a similar manner, often without accepting any payment.

Many of his patients were referred by David Cauldwell, Robert Stoller, and doctors in Denmark. These doctors received hundreds of requests from individuals who had read about their work connected with changing sex, as it was then largely described.

However, due to the personal political opinions of the American doctors and a Danish law prohibiting sex reassignment surgery on noncitizens, these doctors referred the letter-writers to the one doctor of the era who would aid transsexual individuals, Harry Benjamin.[18] Benjamin conducted treatment with the assistance of carefully selected colleagues of various disciplines (such as psychiatrists C. L. Ihlenfeld and John Alden, electrologist Martha Foss, and surgeons Jose Jesus Barbosa,[19] Roberto C. Granato, and Georges Burou).

Benjamin's patients regarded him as a man of immense caring, respect and kindness, and many kept in touch with him until his death. He was a prolific and assiduous correspondent, in both English and German, and many letters are archived at the Magnus Hirschfeld Archive for Sexology, Humboldt University, Berlin.[20]

The legal, social and medical background to this in the United States, as in many other countries, was often a stark contrast, since wearing items of clothing associated with the opposite sex in public was often illegal, anything seen as homosexuality was often persecuted or illegal, and many doctors considered all such people (including children) at best denied any affirmation of their gender identity, or involuntarily subjected to treatments such as drugged detention, electroconvulsive therapy, or lobotomy.[citation needed].

Though he had already published papers and lectured to professional audiences extensively, Benjamin's 1966 book, The Transsexual Phenomenon, was especially important as the first large work describing and explaining the affirmative treatment path he pioneered.[21] Publicity surrounding his patient Christine Jorgensen brought the issue into the mainstream in 1952 and led to a great many people presenting for assistance, internationally. In the preface of Christine Jorgensen's autobiography, Dr. Benjamin also gives Jorgensen credit for the advancement of his studies. He wrote, "Indeed Christine, without you, probably none of this would have happened; the grant, my publications, lectures, etc."[22]

Similar cases in other countries (such as that of Roberta Cowell, whose surgery by Harold Gillies in England was in 1951 but was not publicised until 1954; Coccinelle[23] who received much publicity in France in 1958, and April Ashley, whose exposure in 1961 by the British tabloid press was reported worldwide) fuelled this. But most of Benjamin's patients lived (and many still live) quiet lives.[citation needed]

Reed Erickson (1917–1992), a successful industrialist, sought treatment from Benjamin in 1963.[14] Erickson was the founder and funder of the Erickson Educational Foundation, which published educational booklets, funded medical conferences, counselling services, and the establishment of gender clinics. The EEF funded the Harry Benjamin Foundation.[24][14]

Other work and interests

[edit]

Apart from endocrinology and sexology, he worked on life extension and now would be described as a gerontologist. Benjamin lived to be 101.

Benjamin dedicated his 1966 major work to Gretchen. They were married for 60 years.[25] They were married December 23, 1925.[25] Gretchen revealed to Charles L. Ihlenfeld that "about six months after they were married Harry brought his mother from Germany to live with them" and that "from then on their bedroom door remained open".[25]

In 1979, the Harry Benjamin International Gender Dysphoria Association was formed, using Benjamin's name by permission. The group consists of therapists and psychologists who devised a set of Standards of Care (SOC) for the treatment of gender dysphoria, largely based on Benjamin's cases, and studies.[26] It later changed its name to The World Professional Association for Transgender Health (WPATH).

Bibliography

[edit]

See also

[edit]

Notes

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Harry Benjamin

View on Grokipedia
from Grokipedia
Harry Benjamin (January 12, 1885 – August 24, 1986) was a German-born American endocrinologist and sexologist recognized for initiating systematic medical interventions for individuals experiencing transsexualism, a condition he characterized as an intractable mismatch between psychological sex and anatomical sex. After studying medicine in Germany and immigrating to the United States in 1913 amid the outbreak of World War I, Benjamin built a career in endocrinology and geriatrics, leveraging hormone therapies initially developed for aging patients to address transsexual distress starting in the 1940s. His clinical practice emphasized empirical observation over dominant psychoanalytic explanations, treating hundreds of patients with estrogen or testosterone to induce secondary sex characteristics aligned with their self-perception, often in collaboration with surgeons for genital reconstruction. Benjamin's seminal work, The Transsexual Phenomenon (1966), synthesized over a decade of case studies to delineate transsexualism as distinct from transvestism and , proposing a sex-orientation scale and advocating multidisciplinary evaluation prior to irreversible procedures. This text laid foundational criteria for diagnosis and management, influencing the formation of professional bodies like the Harry Benjamin International Association (later WPATH), though his outsider status in mainstream medicine positioned him as a persistent against institutional resistance. Reports from his patients underscored subjective improvements in following hormonal and surgical interventions, which Benjamin attributed to biological underpinnings potentially rooted in , predating contemporary genetic and neuroscientific inquiries. Despite acclaim for humanizing transsexual care, Benjamin's legacy includes debates over the long-term outcomes of youth interventions he endorsed in select cases and the causal mechanisms of the condition, with some empirical reviews questioning sustained satisfaction rates post-surgery amid evolving diagnostic paradigms. His approach prioritized patient-reported alleviation of through physiological alignment, reflecting a pragmatic realism that challenged era-specific taboos while anticipating critiques of over-medicalization in biased institutional narratives.

Early Life and Education

Childhood and Family Background

Harry Benjamin was born on January 12, 1885, in , , into a prosperous middle-class family. His father, Julius Benjamin, worked as a , providing financial stability that supported the household's assimilated lifestyle. As the eldest of three children, Benjamin grew up in a Lutheran environment, with his German mother and a father who had converted from to , reflecting the era's trends toward religious assimilation among urban Jewish-origin families. The family's home avoided open discussions of sexuality, emphasizing decorum and conformity in line with bourgeois Prussian values. Berlin's dynamic cultural milieu, including early access to technologies like the , offered exposure to and music, sparking Benjamin's childhood fascination with performers such as and . He attended the Königliches Wilhelms-Gymnasium for , receiving a rigorous classical training that prepared him for higher studies amid the city's intellectual vibrancy. This upbringing instilled a sense of upward mobility typical of Berlin's , though subtle prejudices tied to his father's Jewish heritage occasionally surfaced despite the family's Christian orientation. Such dynamics contributed to Benjamin's early navigation of social expectations and in pre-World War I .

Medical Training in Germany

Harry Benjamin, born in in 1885, commenced his medical studies in around 1903, attending universities including those in before completing his Doctor of Medicine degree at the in 1912. His doctoral dissertation focused on , reflecting the era's emphasis on infectious diseases amid 's advanced initiatives. The German medical curriculum at the time demanded extensive clinical rotations, laboratory work, and examinations, fostering a commitment to and physiological understanding that characterized pre-World War I training. Post-graduation, Benjamin engaged in practical training in and , applying foundational skills in and treatment within Berlin's system, where exposure to emerging on glandular functions laid groundwork for later interests in hormonal influences. This period coincided with pivotal discoveries in , such as thyroid hormone isolation in 1914, though Benjamin's immediate focus remained on general rather than specialized . The rigorous, data-driven approach of German academia instilled habits of observation and skepticism toward unverified theories, shaping his enduring preference for verifiable patient outcomes over speculative etiologies.

Immigration and Early Professional Career

Arrival and Settlement in the United States

Harry Benjamin first arrived in the United States in February 1913, traveling from to to assist a physician promoting an unverified treatment for . This professional opportunity aligned with his early medical interests, though the collaboration involved questionable methods later regarded as . Initially intending a temporary visit, Benjamin found himself stranded upon the outbreak of in 1914, which disrupted transatlantic travel and prevented his return to . Unable to resume his life in Europe amid the war's uncertainties, Benjamin pursued permanent settlement in the U.S., leveraging his German medical training to adapt to the American system. By 1915, he secured a New York State medical license, enabling legal practice despite challenges in credential recognition for foreign graduates. He established a modest office in Manhattan, navigating initial logistical hurdles such as limited English proficiency and unfamiliarity with U.S. regulatory frameworks for physicians. Settlement proved arduous in the postwar economic turbulence of the , compounded by the starting in 1929, which strained medical practices nationwide through reduced patient affordability and heightened competition. Benjamin sustained his livelihood by focusing on niche endocrinological consultations, though specific financial strains from this era remain undocumented in primary accounts. His Jewish heritage added contextual risks from global antisemitic currents, but primary relocation drivers were wartime stranding and professional rather than immediate in .

Initial Practices in Endocrinology and General Medicine

Upon arriving in New York in February 1913, Harry Benjamin established a private medical practice that soon specialized in , focusing on glandular therapies to address age-related hormonal imbalances. His work emphasized the therapeutic potential of endocrine interventions for metabolism and behavioral aspects of aging, drawing on early extracts like preparations then available for clinical use. Benjamin's Park Avenue office became renowned for treating affluent patients, such as singers, movie stars, and businessmen experiencing midlife declines, with hormone-based regimens continued into the late . In the , he actively promoted and performed the Steinach operation—a unilateral vasoligation procedure designed to stimulate testicular rejuvenation and counteract —reporting outcomes from 22 cases in a 1922 article that interpreted results through an endocrine lens. As synthetic hormones emerged, he integrated estrogens from the late and androgens from the mid-1930s to enhance glandular function and alleviate symptoms of metabolic slowdown. Despite prevailing skepticism within the medical establishment toward such rejuvenative techniques, Benjamin cultivated a robust referral network through demonstrated efficacy in patient vitality and his compassionate application of endocrine principles, solidifying his expertise prior to diversifying into other areas.

Entry into Sexology

Influences from European Sexologists

Harry Benjamin's engagement with European sexology began during his medical training in and continued through professional networks in the era. He first encountered , the pioneering sexologist and founder of the (Institute for Sexual Science), at the inaugural International Conference for Sexual Reform on a Sexological Basis held in in 1921. This meeting, facilitated through police official Dr. 's associate Dr. Kopp, initiated a longstanding professional relationship between the two physicians. Throughout the 1920s and into the early 1930s, Benjamin made repeated visits to , where he consulted with Hirschfeld at the Institute for Sexual Science, established in 1919 as the world's first dedicated center for sexological research and clinical treatment. The Institute's extensive cataloging of sexual variations—including detailed case studies on , (termed "transvestism" by Hirschfeld in his 1910 Die Transvestiten), and intermediary sexual types—provided Benjamin with empirical models for understanding gender-related nonconformities beyond moralistic or psychiatric pathologization. Hirschfeld's emphasis on biological and psychological continua in , rather than rigid binaries, informed Benjamin's later empirical orientation, distinguishing it from prevailing Freudian or degenerative theories prevalent in early 20th-century . Benjamin's exposure extended to Weimar Berlin's broader clinical landscape, including consultations at specialized facilities where sexologists documented cross-dressing and homosexual behaviors amid the era's relative openness to scientific inquiry into sexuality. These interactions acquainted him with Hirschfeld's advocacy for legal reforms, such as decriminalizing homosexuality via Paragraph 175 repeal efforts, and practical interventions like issuing "transvestite passes" to allow public cross-dressing without arrest. The Nazi regime's ransacking and burning of the Institute's library on May 6, 1933—destroying over 20,000 volumes and irreplaceable patient records—severed this direct lineage, but Benjamin's prior immersion sustained his commitment to evidence-based sexology in exile.

Early Writings on Transvestism

In the early , Harry Benjamin began publishing articles on transvestism in medical and journals, framing it as a distinct psychosomatic condition involving periodic for emotional relief and sexual gratification, rather than mere or perversion. His 1953 piece "Transvestism and Transsexualism" in the International Journal of Sexology outlined initial clinical observations from patient consultations, emphasizing transvestism's roots in an innate drive rather than environmental factors. This was followed by his 1954 contribution to the American Journal of Psychotherapy, "Transsexualism and Transvestism as Psychosomatic and Somato-Psychic ," where he described transvestism as a bridging somatic and psychic elements, often manifesting in heterosexual men who experienced as a compulsion to alleviate inner tension without desiring permanent anatomical change. Benjamin drew these insights from direct examinations and extensive correspondence with self-identified transvestites, noting patterns of episodic dressing that provided psychological equilibrium without broader social disruption. Benjamin explicitly rejected pathologizing transvestism as a mental illness, portraying the "true transvestite" as a harmless variant of integrated into otherwise normal functioning, provided no criminal acts accompanied the behavior. He advocated for societal tolerance and legal non-interference, arguing that punitive measures exacerbated distress without addressing the underlying , and recommended supportive counseling or mild hormonal interventions only if requested to mitigate symptoms. This stance contrasted with contemporaneous psychiatric views that often conflated with deviance, positioning Benjamin's work as an early call for destigmatization based on empirical case patterns rather than moral judgment. A core element of Benjamin's analysis was distinguishing transvestism from , underscoring that the majority of cases involved heterosexual orientation toward women, with serving as an adjunct to, not a substitute for, normative sexual relations. He observed that while some bisexual elements might appear during episodes of dressing, the baseline attraction remained to the opposite anatomical sex, challenging assumptions of inherent linkage between and same-sex desire. These differentiations relied on self-reports from dozens of correspondents and examinees, highlighting transvestism's prevalence among married, professionally successful men who maintained family lives outside their private inclinations.

Clinical Work with Transsexual Patients

Distinguishing Transvestism from Transsexualism

In the mid-1950s, Harry Benjamin identified a distinct clinical population among his patients who expressed an insistent desire for complete reassignment, including surgical alteration of their genitals and living permanently as , in contrast to transvestites who typically engaged in episodically for psychological relief without seeking such irreversible changes. This differentiation arose from his consultations with individuals whose self-reports revealed a profound incongruence between their psychological and anatomical , marking a departure from earlier conceptualizations that lumped behaviors under transvestism alone. Benjamin's empirical observations highlighted transsexuals' persistent body , characterized by intense aversion to their primary and secondary characteristics—described by patients as "disgusting deformities that must be changed" or sources of "heart-breaking anguish"—which persisted regardless of and drove demands for medical intervention to align body with identity. In transvestites, however, provided fetishistic or emotional relief, often equated to "a continuous " or tension release, with no equivalent ongoing torment over ; their behaviors were typically solitary, hobby-like, and compatible with retaining their assigned role in daily life. These patterns, drawn from direct patient histories rather than theoretical imposition, underscored transsexualism as a somatopsychic originating from an innate gender misalignment, distinct from the psychosomatic elements of . The 1952 case of , whose hormone treatments and in garnered international publicity, amplified Benjamin's awareness of this phenomenon by prompting similar individuals to seek his counsel, though he did not perform her procedures. Jorgensen's transformation exemplified the drive for full embodiment, influencing Benjamin's framework without constituting direct treatment on his part, as her care was managed by European colleagues like Christian Hamburger. This public visibility, combined with Benjamin's accumulating case data, solidified his view of transsexualism as a for affected individuals, separable from transvestism's more circumscribed satisfactions.

Diagnostic Framework and Treatment Protocols

Benjamin's diagnostic framework centered on clinical interviews to assess the degree of gender disorientation, employing his Sex Orientation Scale (S.O.S.), a seven-point spectrum ranging from 0 (exclusive identification with natal sex) to 6 (complete transsexualism characterized by rejection of natal sex and full adoption of the opposite). required persistent, intense cross-sex identification from an early age, absence of or severe mental illness, and adult status, with transsexualism posited as a constitutional condition potentially rooted in neuroendocrine factors rather than reversible . Treatment began with administration to induce secondary sex characteristics aligned with the patient's identified sex—primarily estrogens and anti-androgens for male-to-female cases—prioritizing endocrinological intervention based on observed symptomatic relief and Benjamin's prior experience with hormonal therapies in non-transsexual contexts. was recommended concurrently as supportive, focusing on coping and adjustment rather than alteration, given Benjamin's rejection of it as a standalone cure for what he viewed as an innate mismatch. Surgical referral followed only after demonstrated persistence through and a real-life test, wherein patients lived full-time in their affirmed , including , name changes, and societal integration, to confirm functionality and reduce regret risks. Benjamin collaborated with surgeons like Erwin Kohler for vaginoplasties and other procedures, ensuring medical oversight. From the 1960s to 1970s, he managed roughly 1,500 patients, the majority male-to-female (approximately 392 documented in one cohort versus 71 female-to-male).

Case Studies and Patient Outcomes

Harry Benjamin documented outcomes from his clinical practice involving approximately 152 male-to-female patients and 20 female-to-male patients as of 1965, with many receiving and referrals for surgery. Follow-up data, spanning 3 months to 16 years (average 5-6 years), indicated that surgical interventions generally led to improved adjustment for most patients, though results varied by individual circumstances. Among 51 postoperative male-to-female cases reviewed, 17 (33%) achieved good outcomes, 27 (53%) satisfactory, 5 (10%) doubtful, and 1 (2%) unsatisfactory, yielding roughly 86% positive or neutral results based on self-reported , , and psychological relief. Notable cases illustrated these patterns. "Harriet," operated on in her late 20s, reported marital happiness and plans for years post-surgery, despite an internal and delayed healing as complications. "Clara," who transitioned at age 58 and lived as a for nine subsequent years, maintained a stable life without reported regrets. Conversely, "Joan," a 26-year-old post-surgery , succumbed to a amid issues. Pre-treatment occurred in cases like "," a 30-year-old denied , attributed by Benjamin to unaddressed rather than inherent pathology. Regret was rare; among 15 contacted postoperative , none expressed it, though one 64-year-old reported dissatisfaction due to failed and economic hardship. Complications from included fistulas between the neovagina and , infections requiring douches, urinary issues like urethrocystitis, and necessitating revisions; infections and insufficient lubrication were also noted. , primarily estrogens for male-to-female patients, carried risks such as and potential cardiovascular effects, though Benjamin emphasized gradual administration to mitigate unknowns. For female-to-male patients, limited data showed benefits in 15 of 20 cases from hormones and procedures like , with seven achieving good or excellent results post-mastectomy. Long-term tracking was constrained by patient mobility and reluctance to follow up, with Benjamin attributing occasional suicides or poor outcomes more to societal stigma and pre-existing despair than treatment itself. Aggregate from his practice suggested low regret rates in the 1-2% range for operated cases, contrasting with higher pretreatment self-harm attempts (e.g., 4 of 152 males attempted genital ).
Outcome CategoryMale-to-Female (n=51 postoperative)Notes
Good17 (33%)Full social/psychological adjustment
Satisfactory27 (53%)Partial relief, minor ongoing issues
Doubtful5 (10%)Ambiguous improvement
Unsatisfactory1 (2%)Regret or failure

Key Publications and Theoretical Contributions

The Transsexual Phenomenon (1966)

The Transsexual Phenomenon, published in 1966 by Julian Press, synthesized Harry Benjamin's clinical observations from over 200 male and 27 female patients into a framework distinguishing transsexualism from transvestism and advocating biological interventions over psychological adjustment. The book detailed 51 male and 11 female cases involving surgical conversions, emphasizing persistent gender disharmony unresponsive to therapy. Benjamin proposed an inborn predisposition, potentially rooted in endocrine factors such as prenatal hormonal influences or hypogonadism observed in 40% of cases, leading to a neurophysiological mismatch between brain gender identity and somatic sex. He integrated genetic possibilities, like associations with Klinefelter syndrome, and environmental conditioning as secondary contributors, but stressed the etiology's obscurity pending further research. Benjamin critiqued dominant psychoanalytic paradigms, which attributed transsexualism to aberrant childhood experiences or unresolved Oedipal conflicts, as empirically unsupported and clinically futile. He cited instances where years of failed to alleviate distress, arguing such approaches imposed mind-over-body conformity that exacerbated suffering rather than addressing an organic discord. In contrast, he endorsed —such as estrogens for males—and surgical procedures like , , and , reporting improved psychosocial functioning in operated patients who integrated as their identified . This medical realism prioritized alleviating verifiable symptoms through bodily alignment, drawing on case outcomes where non-intervention led to risks or institutionalization. The work's empirical foundation rested on anecdotal clinical data without controlled studies or long-term follow-ups, limiting causal inferences to hypothesis rather than verification. Benjamin acknowledged surgical techniques' imperfections, including complication risks and functional inadequacies, alongside the absence of objective diagnostics. While advancing recognition of transsexualism as a treatable condition distinct from fetishistic , the model's reliance on observed patterns over experimental evidence invited scrutiny, particularly regarding unproven endocrine etiologies and exclusion of variants. In The Transsexual Phenomenon (1966), Harry Benjamin introduced the Sex Orientation Scale (S.O.S.), a seven-point classification system (levels 0 through 6) designed to differentiate degrees of sex and gender role disorientation among males exhibiting transvestic or transsexual tendencies. The scale progressed from level 0, representing typical male heterosexual orientation with no cross-gender elements, to level 6, denoting full transsexualism characterized by complete psychic identification with the female role and pursuit of surgical sex reassignment. Benjamin emphasized a continuum influenced by the Kinsey scale's approach to sexual orientation but adapted to assess gender identity variance, distinguishing fetishistic transvestism at lower levels from profound cross-sex identification at higher ones. The S.O.S. integrated three evaluative dimensions: somatic (physical manifestations, such as frequency or post-hormonal/surgical changes), (internal conviction, ranging from mild discomfort to feeling "trapped in the wrong body"), and social (behavioral , including part- or full-time living in role). Levels 1–3 captured transvestic subtypes (pseudo-, fetishistic, and true), where was periodic or habitual but retained male identity; levels 4–6 marked transsexual progression, with increasing demands for hormones and to align body with psyche. Benjamin noted that higher levels often correlated with diminished and asexual or bisexual orientations post-transition, based on observed patient patterns.
LevelTypeSomatic GradeSocial Grade
0Normal maleNoneMasculineHeterosexual male
1Pseudo-transvestiteMinimal (occasional dressing)Slight gender discomfortMinimal cross-living; heterosexual
2Fetishistic transvestiteModerate (frequent dressing)Moderate discomfortOccasional ; heterosexual
3True transvestiteModerate to strongStrong discomfortPartial cross-living; heterosexual
4Nonsurgical MarkedHigh (wavering identity)Moderate cross-living; asexual/bi
5True (moderate)HighSevere (feminine conviction)Full cross-living; low
6True (high intensity)Complete (post-surgical)Complete female identityFully integrated as female
Benjamin derived the scale empirically from clinical observations of approximately 150 patients by 1965, supplemented by case histories, autobiographies, and responses to in over 100 cases. He analyzed conditioning factors in 122 patients, finding no clear environmental causation in 56% and doubtful evidence in 26%, favoring innate predispositions observable through consistent self-reports of childhood cross-gender behaviors. Physiological tests, such as assays and chromosomal evaluations, supported somatic assessments but did not alter the psychic-social typology. This typology contributed to subsequent diagnostic frameworks by providing a graduated model for gender incongruence, informing the DSM-III (1980) criteria for gender identity disorder through its emphasis on persistent cross-sex identification over mere . Benjamin's scale underscored measurable variances in patient presentations, aiding clinicians in tailoring interventions from supportive at lower levels to medical transition at higher ones.

Establishment of Professional Standards

Founding of the Harry Benjamin International Gender Dysphoria Association

The Harry Benjamin International Gender Dysphoria Association (HBIGDA) was conceived during the Fifth International Symposium on in , in 1977, following the dissolution of the Erickson Educational Foundation, which had previously sponsored such gatherings. It was formally approved at the Sixth Symposium in in 1979 and incorporated as a nonprofit on September 14, 1979, in by Paul Walker, Walter Meyer III, and Alice Webb. Founding members included Paul A. Walker (psychologist and founding president), Richard Green (psychiatrist), Donald R. Laub (surgeon), and Leah Schaefer (psychoanalyst), reflecting an initial emphasis on multidisciplinary collaboration among professionals, endocrinologists, and surgeons to address the clinical needs of gender-dysphoric patients. Named in honor of Harry Benjamin, the endocrinologist whose clinical observations had highlighted the distinction between transvestism and transsexualism since the , HBIGDA aimed to institutionalize peer-reviewed protocols for patient evaluation and referral amid a lack of broader medical consensus on care. Benjamin, then in his mid-90s and operating largely in professional isolation due to skepticism from mainstream and , endorsed the effort as a means to facilitate surgeon referrals and establish shared standards grounded in empirical case outcomes rather than purely psychoanalytic approaches. The association's formation responded to practical challenges, such as coordinating and surgical interventions, by fostering networks among specialists who had treated small numbers of patients based on Benjamin's diagnostic framework. Early activities centered on biennial international symposia, which empirically examined eligibility for interventions through presentations on histories, hormonal responses, and surgical results, prioritizing observable outcomes over theoretical etiologies. These gatherings, building on prior symposia since 1969, emphasized multidisciplinary input to refine referral practices and mitigate risks, such as postoperative regret, informed by Benjamin's decades of follow-up data on over 1,500 cases. By uniting isolated practitioners, HBIGDA sought to elevate the field from ad hoc clinical work to a structured professional domain, countering institutional reluctance evident in the era's limited insurance coverage and ethical debates.

Development of Early Standards of Care

The Harry Benjamin International Gender Dysphoria Association (HBIGDA), founded in 1979 and drawing directly from Benjamin's clinical framework, issued the first Standards of Care (SOC) that year to guide the evaluation and treatment of transsexual patients. These initial guidelines mandated a rigorous diagnostic process by qualified mental health professionals to confirm persistent gender dysphoria, distinguishing it from transient or comorbid conditions like fetishistic cross-dressing or psychiatric disorders. Hormone therapy was permitted only after this diagnosis, typically following a period of psychotherapy to assess the stability of the patient's identity and rule out reversible factors, reflecting Benjamin's emphasis on verifiable, longstanding incongruence rather than immediate accommodation of self-reported desires. Central to the 1979 SOC was a staged progression designed to test commitment and reduce postoperative regret rates, which Benjamin had observed could exceed 10% in less vetted cases from earlier European clinics. Candidates for cross-sex hormones were required to demonstrate psychological readiness, with therapy often spanning months to years before initiation. Genital surgery was prohibited without at least one year of continuous hormone administration and a "real-life experience" (RLE) in the desired social role, during which patients navigated daily life, employment, and relationships without reverting to their birth sex presentation. This gatekeeping aimed to ensure interventions addressed a profound, immutable mismatch rather than situational distress, prioritizing outcomes where patients achieved sustained adaptation over rapid medicalization. For adolescents, the early SOC advocated extreme caution, limiting interventions to reversible measures like counseling or puberty-delaying analogs only in exceptional cases of severe, documented persistence into late puberty, with irreversible steps deferred until adulthood. Benjamin's influence here stemmed from his sexology scale, which weighted higher degrees of transsexualism by lifelong conviction and adult-onset irreversibility, viewing juvenile cases as often desisting without intervention—rates he estimated at up to 80% based on follow-up data from his practice. This approach sought causal fidelity by favoring empirical persistence over acquiescence to youthful declarations, thereby safeguarding against iatrogenic harm in developmentally fluid periods.

Criticisms, Controversies, and Alternative Perspectives

Debates with Psychiatrists on Psychotherapy vs. Medical Intervention

Benjamin engaged in ongoing debates with psychiatrists and psychoanalysts who viewed transsexualism primarily as a psychological disorder amenable to curative , often attributing it to unresolved oedipal conflicts, pre-oedipal fixations, or delusional defenses against underlying . Prominent critics, including psychoanalyst Charles Socarides, classified transsexualism as a severe perversion or rooted in developmental arrests, advocating intensive to uncover and resolve these psychic origins rather than endorsing hormonal or surgical interventions, which they saw as enabling . Socarides and like-minded professionals argued that medical treatments bypassed essential therapeutic work, potentially exacerbating issues by affirming what they deemed a pathological rejection of biological reality. In response, Benjamin maintained that transsexualism possessed a constitutional or biological component resistant to purely psychotherapeutic resolution, drawing on clinical observations from over 1,500 cases where extended analysis failed to alleviate core and sometimes intensified patient distress, such as through deepened feelings of invalidation or prolonged denial of identity. He cited empirical outcomes showing rapid symptom relief— including reduced suicidality and improved social functioning—following hormone administration, even in patients previously deemed "treatment-resistant" by psychiatrists, positioning medical intervention as causally aligned with the condition's somatic underpinnings rather than a psychological overlay. While acknowledging psychotherapy's role in screening for comorbidities or aiding postoperative adjustment, Benjamin critiqued psychiatric conservatism as empirically unsubstantiated, noting low postoperative rates (under 1% in his cohort) compared to high pretreatment attempts (up to 50% in some reports). These debates highlighted tensions between psychoanalytic , which prioritized intrapsychic causation, and Benjamin's endocrinological framework emphasizing observable physiological responses to treatment. Critics countered that Benjamin's approach risked overtreatment by sidelining rigorous psychiatric , potentially overlooking co-occurring conditions like depression or personality disorders that mimicked or compounded , though Benjamin mandated consultations and reserved final decisions for medical judgment when proved futile. His advocacy ultimately shifted clinical paradigms toward multimodal care, reducing acute suffering in cases, but sparked enduring concerns over insufficient gatekeeping in early protocols.

Concerns Over Long-Term Efficacy and Ethical Issues

Critics have questioned the long-term efficacy of Benjamin's treatment protocols, which emphasized and surgery for select patients, due to the absence of randomized controlled trials or placebo-controlled studies that could establish causality between interventions and sustained improvements in . Benjamin's own follow-ups, drawn from small clinical samples of dozens to hundreds of patients, reported regret rates as low as 1-2%, but these lacked systematic long-term tracking beyond a few years and were susceptible to , as dissatisfied patients may have disengaged from care. Subsequent analyses of early postoperative cohorts have similarly highlighted methodological gaps, including short observation periods and no comparison to non-surgical outcomes, complicating attributions of benefits to medical transition amid confounding factors like or social adaptation. Contemporary evidence underscores data limitations in affirming universal efficacy, with rates in modern studies varying from 2.1% for internal motivations to 10-13% overall, often exceeding historical claims and linked to unresolved comorbidities or shifts in self-perception. A 2011 Swedish of 324 post-sex reassignment individuals found elevated risks of mortality, suicidality, and psychiatric hospitalization compared to matched controls, persisting up to 30 years post-treatment, suggesting that interventions may not resolve underlying vulnerabilities and could exacerbate them without addressing root causes such as trauma or neurodevelopmental factors. These findings, derived from national registries rather than clinic self-reports, contrast with affirmative narratives in healthcare literature, where methodological rigor is often lower due to ethical barriers to withholding treatment, perpetuating reliance on observational data prone to bias. Ethical concerns center on the irreversibility of interventions like or , which preclude fertility without contemporaneous preservation techniques—rare in Benjamin's era—and carry risks such as from estrogen-induced in male-to-female cases or cardiovascular complications from testosterone in female-to-male. Informed consent processes face challenges when long-term uncertainties, including potential regret amid evolving identity or external pressures, are not fully conveyed, particularly given the absence of high-quality prognostic data at the time. Proponents of alternative approaches, such as extended or intensive , argue these prioritize reversible explorations of dysphoria's —debated as innately biological versus environmentally influenced—over hasty , citing ethical imperatives to minimize harm from unproven causal pathways. Such critiques highlight trade-offs in prioritizing affirmation, as institutional biases in academia and may underemphasize non-affirmative to avoid stigmatizing patients.

Heteronormative Assumptions and Binary Focus in His Work

Benjamin's framework for transsexualism presupposed a strict binary of male and female roles, positing that individuals experienced an innate mismatch between their psychological and anatomical sex, necessitating transition to fully embody socially, legally, and sexually. In The Transsexual Phenomenon (1966), he described transsexuals as seeking to "function as members of ," with successful outcomes involving integration into traditional roles, such as male-to-female patients living as "inconspicuous girls" or pursuing marriage and motherhood. This binary orientation reflected mid-20th-century endocrinological and psychiatric understandings, where was tied to dimorphic biological norms rather than fluidity or spectra. Central to his model was the expectation of heterosexual adjustment post-transition, which he viewed as evidence of authentic . Benjamin noted that many male-to-female transsexuals were attracted to men, pursuing "normal boyfriends who treat them as girls" and aiming for legal after surgery to overcome anatomical barriers to such relationships. His Sex Orientation Scale (S.O.S.) reinforced this by classifying "true transsexuals" (Types V and VI) as those with moderate to high intensity disorientation coupled with predominantly or exclusively heterosexual orientation in the target —equivalent to ratings of 4-6 or 6, meaning attraction primarily or solely to men pre-transition for male-to-female cases, aligning with post-transition . Case studies, such as Clara's 30-year to a man and multiple orgasms in heterosexual contexts post-surgery, exemplified this desired outcome. Benjamin expressed skepticism toward transsexuals exhibiting homosexual inclinations relative to their birth sex, distinguishing them from "true" cases and often aligning them closer to or transvestism. He observed that transsexuals frequently disliked homosexuals and rejected homosexual experiences as unsatisfactory, insisting that transsexual attraction to the anatomical same sex did not constitute because "they feel they belong to the sex to that of the chosen partner." Such patients were deemed rarer and subject to greater psychiatric scrutiny, with lower S.O.S. types (e.g., IV) showing more variable orientations not fully endorsing binary heterosexual . While this approach legitimized and surgery for binary-identified patients whose post-transition goals matched heterosexual norms—comprising the majority of his clinical successes and enabling "happier futures" through role alignment—critics contend it imposed heteronormative gatekeeping that marginalized or non-binary identities. By prioritizing androphilic male-to-female cases as paradigmatic, Benjamin's criteria excluded gynephilic individuals, potentially delaying care for those not fitting the model and embedding expectations of in early standards of care. Contemporary reassessments, informed by greater visibility of gender diversity, argue that his binary-heterosexual emphasis pathologized variance outside these norms, framing deviations as lesser forms of the condition rather than valid expressions, though his era-limited observations aligned with the patient demographics he encountered.

Broader Contributions and Later Years

Work in Endocrinology and Gerontology

Harry Benjamin established a clinical practice in specializing in and , where he applied hormone therapies to address age-related endocrine deficiencies in non-transgender patients. His work emphasized biological interventions over psychosomatic interpretations, positing that glandular imbalances were primary drivers of symptoms like , reduced vitality, and in older adults. Benjamin's approach drew from early 20th-century advances in hormone isolation, advocating empirical testing of glandular extracts and sex steroids to restore physiological function. In treating elderly men, Benjamin prescribed testosterone to counteract andropause-like symptoms, reporting improvements in energy, , and overall based on patient outcomes. He personally administered testosterone to himself into advanced age, reflecting confidence in its efficacy for mitigating . For women, he combined estrogens and androgens in geriatric patients, administering these to 88 individuals aged 43 to 73 under the hypothesis that gonadal hormone deficits universally accompany aging. These regimens targeted metabolic disturbances and sexual function, with Benjamin documenting subjective gains in physical and psychological vigor, though long-term data remained limited by the era's methodological constraints. Benjamin's publications, such as his 1949 article "Endocrine Gerontotherapy: The Use of Combinations in Female Patients," underscored a causal framework wherein supplementation directly addressed root endocrine failures rather than secondary psychological factors. This perspective aligned with his broader rejection of purely environmental or mental explanations for physiological decline, favoring observable hormonal correlations from clinical observations. By the late 1940s, however, his aggressive protocols for faced growing amid emerging evidence of risks like cardiovascular effects, positioning his methods as innovative yet increasingly divergent from mainstream .

Personal Life and Death

Harry Benjamin married Gretchen Amelung in 1925, a union that lasted until his death and to whom he dedicated his 1966 book The Transsexual Phenomenon. The couple had no children and resided frugally in a Murray Hill apartment in , where Benjamin maintained a modest lifestyle despite his professional success. He continued a lifelong hobby of playing the into his later years, reflecting personal resilience amid a marked by professional isolation on certain topics. Benjamin attributed his exceptional in part to disciplined habits and his interests in , including hormone therapies for aging, which he applied to geriatric patients and possibly himself. He received late-career recognitions from medical and organizations, including awards documented through 1975, and persisted in consulting patients into his eighties before retiring around age 90. Benjamin died on August 24, 1986, at age 101 in his apartment, succumbing to natural causes associated with advanced age. His endurance underscored a personal fortitude that paralleled his unconventional professional pursuits.

Legacy and Contemporary Impact

Influence on Modern Transgender Healthcare

The Harry Benjamin International Gender Dysphoria Association (HBIGDA), founded in 1979 and named in honor of Benjamin, directly extended his clinical framework by publishing the first Standards of Care (SOC) that year, outlining protocols for diagnosing , initiating , and approving surgeries after psychological assessment. These initial SOC documents, revised in subsequent versions through 1981, codified Benjamin's emphasis on a multidisciplinary approach involving endocrinologists, surgeons, and therapists to evaluate patient suitability for irreversible interventions, thereby establishing a template for medical treatment that prioritized phenotypic alignment with identified over exploratory alone. HBIGDA's SOC influenced the proliferation of specialized gender clinics in the United States and during the 1980s and 1990s, standardizing practices that had previously varied widely and lacked consensus. Upon HBIGDA's renaming to the World Professional Association for Transgender Health (WPATH) in 2007, the SOC evolved into versions 7 (2012) and 8 (2022), retaining core elements from Benjamin's model such as real-life experience requirements and informed consent processes, which continue to underpin global guidelines adopted by bodies like the Endocrine Society and various national health services. This continuity ensured Benjamin's causal role in shifting transgender healthcare from ad hoc interventions to protocol-driven care, facilitating access for individuals with persistent, severe dysphoria by legitimizing medical pathways in institutional settings previously resistant to such treatments. However, the entrenched medicalization inherent in these standards has been noted to marginalize non-interventionist alternatives, potentially foreclosing empirical exploration of psychosocial factors in dysphoria resolution prior to physical changes. Benjamin's legacy in this domain empirically marked a transition from outright denial of transsexualism as a treatable condition—prevalent in mid-20th-century —to affirmative intervention models, enabling thousands of procedures worldwide under structured oversight, though subsequent reviews highlight the need for rigorous longitudinal outcome studies to validate long-term efficacy beyond anecdotal reports from early cohorts. While achieving reduced procedural risks through standardized preoperative evaluations, the model's binary focus on cross-sex hormones and as primary remedies has constrained diversification toward reversible or watchful-waiting options in milder presentations.

Reassessments in Light of Current Evidence on Treatments

Recent systematic reviews of longitudinal studies indicate that 60-90% of children and adolescents diagnosed with desist from their by adulthood without medical intervention, with desistance rates averaging around 80% in pre-pubertal cohorts followed into maturity. These findings, drawn from clinic-based cohorts in the and spanning decades, challenge models assuming persistence and underscore the risks of early , as desistance often correlates with puberty's onset and resolution of comorbidities like autism or trauma. The 2024 Cass Review, commissioned by the , concluded that evidence for blockers and hormones in youth is "remarkably weak," with no robust randomized controlled trials (RCTs) demonstrating benefits for or reduction, and potential harms including loss and fertility impairment. This led to an indefinite ban on blockers for under-18s in December 2024, prioritizing exploratory to address underlying factors over affirmative medical pathways. Similarly, Sweden's 2022 national guidelines, based on systematic evidence assessment, restricted hormones for minors to exceptional cases, citing insufficient proof of net benefits and elevated risks of or persistent psychopathology. In adults, long-term follow-up data reveal persistent elevated risks post-transition; a 2011 Swedish of 324 post-sex-reassignment individuals found 19.1 times higher rates and increased psychiatric compared to matched controls, persisting decades after . Reported regret rates hover below 1% in short-term surveys, but methodological flaws—such as 30-50% loss to follow-up and exclusion of —likely underestimate true detransition, which may reach 10-30% in recent youth cohorts per insurance and clinic data. Benjamin's framework, emphasizing psychiatric evaluation, real-life experience, and adult-only interventions, appears prescient in advocating caution against unproven youth treatments amid evidence of social influences and comorbidities driving recent surges in referrals. However, his model's reliance on anecdotal outcomes without RCTs or etiological inquiry into dysphoria's causes—such as neurodevelopmental or environmental factors—limits its applicability, as modern causal research gaps persist despite calls for comorbidity-focused over default affirmation. Proponents of affirmation cite risk reductions in observational studies, yet these lack controls for and show no causal superiority over . Skeptics highlight over-medicalization akin to , urging randomized trials to test alternatives like Benjamin's evaluative approach against rapid transition.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10718274/
  2. https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.2164-0947.1967.tb02273.x
  3. https://www.nytimes.com/1975/01/11/archives/transsexuality-expert-90-recalls-maverick-career.html
  4. https://uncpress.org/9781469674858/wondrous-transformations/
  5. https://papersowl.com/examples/harry-benjamin-a-pioneer-in-transgender-care/
  6. https://zagria.blogspot.com/2012/10/harry-benjamin-1885-1986.html
  7. https://contingentmagazine.org/2024/07/28/harry-benjamin-the-maverick/
  8. https://www.nytimes.com/1986/08/27/obituaries/harry-benjamin-dies-at-101-specialist-in-transsexualism.html
  9. https://dspace.library.uvic.ca/bitstreams/3aa9fbe6-d1ab-4449-86e6-8c51cf762027/download
  10. https://www.nyclgbtsites.org/site/trans-medical-care-at-the-office-of-dr-harry-benjamin/
  11. https://glreview.org/article/the-birth-of-transgender-science/
  12. https://academic.oup.com/endo/article-abstract/6/6/776/2771637
  13. http://www.sexarchive.info/GESUND/ARCHIV/TRANS_B5.HTM
  14. https://magnus-hirschfeld.de/ausstellungen/institute/
  15. https://link.springer.com/article/10.1007/BF01541990
  16. https://psychiatryonline.org/doi/10.1176/appi.psychotherapy.1954.8.2.219
  17. https://digicoll.lib.berkeley.edu/record/120598/files/1961_Mattachine_Vol07_No01_Jan.pdf
  18. https://transreads.org/wp-content/uploads/2019/04/2019-04-07_5ca961529c262_HarryBenjamin-TheTranssexualPhenomenon1copy.pdf
  19. https://www.researchgate.net/publication/247510905_Dear_Doctor_Benjamin_Letters_from_Transsexual_Youth_1963-1976
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC9286744/
  21. https://wpath.org/about/history/international-symposia/
  22. https://wpath.org/about/history/
  23. https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2021/04/the-rise-and-fall-of-gender-identity-clinics-in-the-1960s-and-1970s/
  24. https://academic.oup.com/jcem/article/94/9/3132/2596324
  25. https://www.cpath.ca/wp-content/uploads/2009/12/WPATHsocv6.pdf
  26. https://www.researchgate.net/publication/271927822_Real-Life_Test_Experience_Recommendations_for_Revisions_to_the_Standards_of_Care_of_the_World_Professional_Association_for_Transgender_Health
  27. https://www.researchgate.net/publication/318774646_Harry_benjamin_and_psychiatrists
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC12466298/
  29. https://badfacts.substack.com/p/trans-away-the-gay-therapists-say
  30. https://www.tandfonline.com/doi/pdf/10.1300/J236v08n01_11
  31. https://www.tandfonline.com/doi/abs/10.1300/J236v08n01_11
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC3043071/
  33. https://pubmed.ncbi.nlm.nih.gov/12856892/
  34. https://www.sciencedirect.com/science/article/pii/S0015028208038387
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC8213007/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC10803846/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC10322769/
  38. https://academic.oup.com/jcem/article/88/8/3467/2845109
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC8557156/
  40. https://digitalcommons.liberty.edu/context/lu_law_review/article/1266/viewcontent/4_An_Ethically_Appropriate_Response_to_Individuals_with_Gender_Dysphoria.pdf
  41. https://www.researchgate.net/publication/315597244_Ethical_Concerns_About_Emerging_Treatment_Paradigms_for_Gender_Dysphoria
  42. https://journals.sagepub.com/doi/10.1177/1363460705049578
  43. https://academic.oup.com/geronj/article-abstract/4/3/222/591510
  44. https://link.springer.com/content/pdf/10.1007/BF01542031.pdf
  45. https://transreads.org/wp-content/uploads/2024/10/2024-10-10_6707bf981c214_2023_Li_WonderousTransformations.pdf
  46. https://www.digitaltransgenderarchive.net/files/rf55z7713
  47. https://wpath.org/publications/soc8/soc8-history/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC3359659/
  49. https://wpath.org/about/mission-and-vision/
  50. https://segm.org/false-assumptions-gender-affirmation-minors
  51. https://www.transgendertrend.com/children-change-minds/
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC9829142/
  53. https://cass.independent-review.uk/home/publications/final-report/
  54. https://segm.org/Final-Cass-Report-2024-NHS-Response-Summary
  55. https://www.gov.uk/government/news/ban-on-puberty-blockers-to-be-made-indefinite-on-experts-advice
  56. https://segm.org/segm-summary-sweden-prioritizes-therapy-curbs-hormones-for-gender-dysphoric-youth
  57. https://pubmed.ncbi.nlm.nih.gov/21364939/
  58. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0016885
  59. https://segm.org/regret-detransition-rate-unknown
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC8099405/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC11103900/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC12294553/
Add your contribution
Related Hubs
User Avatar
No comments yet.